Thrombophilia Due To Thrombin Defect; Thph1
Description
Thrombophilia is a multifactorial disorder of inappropriate clot formation resulting from an interaction of genetic, acquired, and circumstantial predisposing factors. Venous thromboembolism most commonly manifests as deep vein thrombosis, which may progress to pulmonary embolism if the clot dislodges and travels to the lung. Other manifestations include thromboses of the cerebral or visceral veins and recurrent pregnancy loss (summary by Seligsohn and Lubetsky, 2001 and Varga and Kujovich, 2012).
Genes related to Thrombophilia Due To Thrombin Defect; Thph1
- F2
- MTHFR
- F13A1
- HABP2
Clinical Features
Phenotypes and symptoms related to Thrombophilia Due To Thrombin Defect; Thph1
- Neoplasm
- Gastrointestinal hemorrhage
- Venous thrombosis
- Thromboembolism
- Pulmonary embolism
- Deep venous thrombosis
- Hypercoagulability
- Cerebral venous thrombosis
- Recurrent deep vein thrombosis
- Recurrent thrombophlebitis
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Thrombophilia Due To Thrombin Defect; Thph1 Is also known as thrombophilia due to factor 2 defect, venous thromboembolism, venous thrombosis.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Thrombophilia Due To Thrombin Defect; Thph1 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Prothrombin.
By Molecular Diagnostic Laboratory University of Alberta (Canada).
F2
Specificity
100 %
Genes
25 % |
Prothrombin Mutation Panel.
By Baylor Miraca Genetics Laboratories (United States).
F2
Specificity
100 %
Genes
25 % |
Thrombophilia Mutation Panel.
By Baylor Miraca Genetics Laboratories (United States).
F2, F5, MTHFR
Specificity
67 %
Genes
50 % |
Prothombin 20210A.
By Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center (United States).
F2
Specificity
100 %
Genes
25 % |
Thrombophilia.
By Center for Human Genetics, Inc (United States).
F2
Specificity
100 %
Genes
25 % |
Prothrombin A20210G Mutation Analysis.
By Molecular Pathology Laboratory University of Pennsylvania Health System (United States).
F2
Specificity
100 %
Genes
25 % |
Prothrombin 20210G>A.
By Molecular Genetics Laboratory Centro de Investigaciones Endocrinologicas "Dr. Cesar Bergada" (Argentina).
F2
Specificity
100 %
Genes
25 % |
Prothrombin.
By Center for Genetics at Saint Francis Saint Francis Hospital (United States).
F2
Specificity
100 %
Genes
25 % |
You can get up to 206 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SHORT-RIB THORACIC DYSPLASIA 3 WITH OR WITHOUT POLYDACTYLY; SRTD3 HYALINE FIBROMATOSIS SYNDROME; HFS HYPERCAROTENEMIA AND VITAMIN A DEFICIENCY, AUTOSOMAL DOMINANT CORNEAL DYSTROPHY, REIS-BUCKLERS TYPE; CDRB CEREBRAL ARTERIOPATHY, AUTOSOMAL DOMINANT, WITH SUBCORTICAL INFARCTS AND LEUKOENCEPHALOPATHY, TYPE 1; CADASIL1